On 31 July 2017
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 31 July 2017, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30 June 17.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
